Data / Drug companies / NuCare Pharmaceuticals, Inc.
NuCare Pharmaceuticals, Inc.: 70 products in the FDA NDC directory, labeler code 66267
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
NuCare Pharmaceuticals, Inc. (labeler code 66267) lists 70 products in the FDA National Drug Code Directory, covering 50 finished drugs by generic name. By type: 64 prescription drugs, 6 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 15, 2017.
The request: Watch NuCare Pharmaceuticals, Inc. (FDA labeler code 66267): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 66267
- Products in commercial distribution
- 70
- Packages
- 171
- Finished drugs by generic name
- 50
- Prescription products
- 64
- Over the counter products
- 6
- Controlled substance products
- Schedule II 1, Schedule III 1, Schedule IV 1
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 1
- Earliest marketing start
- December 14, 1981
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 66 | 94.3% |
| Over the counter monograph drugs | 4 | 5.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 64 | 91.4% |
| Over the counter drugs | 6 | 8.6% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 35 | 50% |
| Capsule | 10 | 14.3% |
| Cream | 6 | 8.6% |
| Tablet, film coated | 4 | 5.7% |
| Powder, for suspension | 3 | 4.3% |
| Ointment | 2 | 2.9% |
| Tablet, chewable | 2 | 2.9% |
| Solution | 2 | 2.9% |
| Tablet, delayed release | 2 | 2.9% |
| Tablet, film coated, extended release | 1 | 1.4% |
| Tablet, extended release | 1 | 1.4% |
| Capsule, liquid filled | 1 | 1.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Oxybutynin Chloride | 66267-642 | Tablet | Generic drugs (ANDA) | November 15, 2017 |
| Gemfibrozil | 66267-436 | Tablet | Generic drugs (ANDA) | July 8, 2016 |
| Naproxen | 66267-373 | Tablet, delayed release | Generic drugs (ANDA) | July 5, 2016 |
| Allopurinol | 66267-665 | Tablet | Generic drugs (ANDA) | April 29, 2015 |
| Doxazosin | 66267-377 | Tablet | Generic drugs (ANDA) | April 22, 2015 |
| Polycin | 66267-925 | Ointment | Generic drugs (ANDA) | November 12, 2014 |
| Acyclovir | 66267-399 | Tablet | Generic drugs (ANDA) | September 10, 2014 |
| Hydrochlorothiazide | 66267-106 | Tablet | Generic drugs (ANDA) | April 10, 2013 |
| Methocarbamol | 66267-803 | Tablet | Generic drugs (ANDA) | March 20, 2013 |
| Methocarbamol | 66267-146 | Tablet | Generic drugs (ANDA) | March 20, 2013 |
| Hydrocodone Bitartrate and Acetaminophen | 66267-319 | Tablet | Generic drugs (ANDA) | April 11, 2012 |
| Indomethacin | 66267-120 | Capsule | Generic drugs (ANDA) | November 1, 2011 |
| Indomethacin | 66267-119 | Capsule | Generic drugs (ANDA) | November 1, 2011 |
| Glyburide | 66267-103 | Tablet | Generic drugs (ANDA) | October 5, 2010 |
| Phendimetrazine Tartrate | 66267-394 | Tablet | Generic drugs (ANDA) | September 15, 2010 |
| Propranolol Hydrochloride | 66267-261 | Tablet | Generic drugs (ANDA) | June 21, 2010 |
| Sulfamethoxazole and Trimethoprim | 66267-816 | Tablet | Generic drugs (ANDA) | February 16, 2010 |
| Sulfamethoxazole and Trimethoprim | 66267-196 | Tablet | Generic drugs (ANDA) | February 16, 2010 |
| Diphenhydramine HCL | 66267-779 | Capsule | Over the counter monograph drugs | January 27, 2010 |
| Diphenhydramine HCL | 66267-081 | Capsule | Over the counter monograph drugs | January 27, 2010 |
| Clonidine hydrochloride | 66267-464 | Tablet | Generic drugs (ANDA) | September 21, 2009 |
| Verapamil hydrochloride | 66267-212 | Tablet, film coated, extended release | Generic drugs (ANDA) | September 17, 2009 |
| Nifedipine | 66267-831 | Capsule | Generic drugs (ANDA) | August 11, 2009 |
| Folic Acid | 66267-217 | Tablet | Generic drugs (ANDA) | January 12, 2009 |
| Ibu | 66267-964 | Tablet | Generic drugs (ANDA) | November 20, 2008 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.